Update! With 2 new 13D
$Cartesian Therapeutics (RNAC.US)$ Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With BuyCartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.SEC announcement13 mins agoCartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael Singer(4.3%),Baharak Asefzadeh(2.6%), etc.SEC announcement19 mins
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more1
T-24Century : looking good hehe
T-24Century : they add around 12m shares and the float is now at 280m from 55m before de added shares.
Trytosaveabit OP T-24Century : I think they have that wrong?
T-24Century : how can you calculate the math?
the price should be maybe 38 -40?
Trytosaveabit OP T-24Century : That depends! Some calculate the market cap using shares in lockup and unregistered shares? Me I just use the price it’s trading at times the number of shares that are available for trading! That’s the difference between Float Market cap and Full Market Capitalization! Hope this help?
T-24Century : thanks master
Trytosaveabit OP T-24Century : You’re very welcome! GL friend!